Johnson & Johnson’s stock rallies after an earnings beat and raised outlook, lifting pharma stocks
Johnson & Johnson’s stock gets a boost from an earnings beat and raised full-year outlook.
Join our subscribers list to get the latest news, updates and special offers directly in your inbox